Evidence map›Paper›PMID 34635157›Full record

ArticleArthritis research & therapy2021

Catastrophic adult-onset Still's disease as a distinct life-threatening clinical subset: case-control study with dimension reduction analysis.

Anaïs Wahbi, Benoît Tessoulin, Cédric Bretonnière, Julien Boileau, Dorothée Carpentier, Olivier Decaux, Laurence Fardet, Guillaume Geri, Pascal Godmer, Cécile Goujard and 7 more

Abstract readMulticenter Study
In one paragraph

Article in Arthritis research & therapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Review
  6. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Anaïs Wahbi *Service de Médecine Interne, PHU3, Centre Hospitalier Universitaire de Nantes - Hôtel-Dieu, 1 Place Alexis Ricordeau, 44093, Nantes, France.
Benoît Tessoulin *Service d'Hématologie, PHU1, CHU Hôtel-Dieu, 44093, Nantes, France.
Cédric BretonnièreService de Pneumologie, PHU2, CHU de Nantes, 44093, Nantes, France.
Julien BoileauService de Médecine, CH de Morlaix, 29672, Morlaix, France.
Dorothée CarpentierService de Réanimation Médicale, CHU de Rouen, 76031, Rouen, France.
Olivier DecauxService de Médecine Interne, CHU de Rennes, 35033, Rennes, France.
Laurence FardetService de Dermatologie, Hôpital Henri Mondor, 94000, Créteil, France.
Guillaume GeriService de Réanimation Médicale, CHU Cochin, AP-HP, 75012, Paris, France.
Pascal GodmerCH Bretagne-Atlantique, 56000, Vannes, France.
Cécile GoujardService de Médecine Interne, CHU Bicêtre, AP-HP, 94270, Kremlin-Bicêtre, France.
Hervé MaisonneuveService de Médecine Interne, CHD Vendée, 85925, La Roche-sur-Yon, France.
Arnaud MariService de Réanimation, Hôpital Yves Le Foll, 22000, St Brieuc, France.
Jacques PouchotService de Médecine Interne, Hôpital Européen Georges Pompidou, AP-HP, 75908, Paris, France.
Jean-Marc ZizaService de Médecine Interne-Rhumatologie, Groupe Hospitalier Diaconesses-Croix-Saint-Simon, 75020, Paris, France.
Sophie Georgin-LavialleService de Médecine Interne, CHU Tenon, AP-HP, 75020, Paris, France.
Mohamed HamidouService de Médecine Interne, PHU3, Centre Hospitalier Universitaire de Nantes - Hôtel-Dieu, 1 Place Alexis Ricordeau, 44093, Nantes, France.
Antoine NéelService de Médecine Interne, PHU3, Centre Hospitalier Universitaire de Nantes - Hôtel-Dieu, 1 Place Alexis Ricordeau, 44093, Nantes, France. antoine.neel@gmail.com.ORCID 0000-0002-7707-5794

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesAdult-onset Still's disease (AOSD) is a rare systemic inflammatory disorder. Diagnosing AOSD can be challenging, as disease presentation and clinical course are highly heterogeneous. For unclear reasons, a few patients develop life-threatening complications. Our objective was to determine whether these cases resulted from therapeutic delay or could represent a peculiar AOSD subset.

methodsWe conducted a multicentre retrospective study of 20 AOSD patients with organ failure requiring intensive care unit admission and 41 control AOSD patients without organ failure. Clinico-biological data at hospital admission were explored using supervised analyses and unsupervised dimension reduction analysis (factor analysis of mixed data, FAMD).

resultsDisease duration before admission was shorter in patients with life-threatening AOSD (median, 10 vs 20 days, p = 0.007). Disease duration before AOSD therapy initiation also tended to be shorter (median, 24 vs 32 days, p = 0.068). Despite this shorter disease duration, FAMD, hierarchical clustering and univariate analyses showed that these patients exhibited distinctive characteristics at first presentation, including younger age; higher frequency of splenomegaly, liver, cardiac and/or lung involvement; less frequent arthralgia; and higher ferritin level. In multivariate analysis, 3 parameters predicted life-threatening complications: lack of arthralgia, younger age and shorter time between fever onset and hospitalisation.

conclusionThis study suggests that life-threatening complications of AOSD occur very early, in a peculiar subset, which we propose to name catastrophic adult-onset Still's disease (CAOSD). Its exact burden may be underestimated and remains to be clarified through large multicentre cohorts. Further studies are needed to identify red flags and define the optimal therapeutic strategy.

Indexed as

Still's Disease, Adult-OnsetAdultCase-Control StudiesHumansMultivariate AnalysisRetrospective StudiesAcute respiratory failureAdult-onset Still’s diseaseCase–control studyClustersCytokine stormDifferential diagnosisIntensive care unitReactive haemophagocytic syndromeShock

Identifiers

PMID34635157
PMCPMC8504015

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.